XOMA develops and manufactures innovative biopharmaceuticals for disease targets including cancer, immunological and inflammatory disorders, and infectious diseases. Our task was to position XOMA as a multiple-drug, multiple-indication company. Through the use of documentary-style photography we highlighted the diversity of the internal infrastructure. The overlaying copy describes the many drug candidates XOMA is developing to treat each disease, and at which stage each candidate is within clinical trial development. The reader walks away with a clear understanding of XOMA’s capabilities, strategy and future developments.